Zystor
Privately-held biotechnology company developing enzyme replacement therapies for the treatment of lysosomal.
Launch date
Employees
Market cap
-
Enterprise valuation
€105m (Public information from Aug 2010)
Milwaukee Wisconsin (HQ)
Authorizing premium user...